A. Mokrowiecka

发表

Clinical, Emotional and Social Factors Associated with Quality of Life in Chronic Pancreatitis

A. Mokrowiecka, D. Pińkowski, E. Małecka-Panas, 2010, Pancreatology.

W. Krajewska, J. Fichna, A. Mokrowiecka, 2019, International journal of molecular sciences.

G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn’s disease

W. Krajewska, R. Kordek, J. Fichna, 2019, Scientific Reports.

First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B

Da I Jung, M. Nöthen, I. V. van Rooij, 2022, HGG advances.

The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north–south gradient among Europeans

M. Nöthen, C. Wijmenga, K. Czene, 2016, European Journal of Human Genetics.

Assessment of quality of life in patients with chronic pancreatitis

A. Mokrowiecka, D. Pińkowski, E. Małecka-Panas, 2011, Medical science monitor : international medical journal of experimental and clinical research.

Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.

M. Vieth, R. Kordek, A. Mokrowiecka, 2017, Pathology, research and practice.

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease

J. Fichna, A. Mokrowiecka, E. Małecka-Panas, 2020, Journal of clinical medicine.

Exploring the Relationship Between Self-Isolation and Distress Among People with Gastrointestinal Disorders During the COVID-19 Pandemic

A. Stengel, C. Bernstein, R. Gearry, 2021, Journal of Clinical Psychology in Medical Settings.

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea‐predominant IBS

W. Krajewska, J. Timmermans, M. Storr, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Circulating Levels of Visfatin, Resistin and Pro-Inflammatory Cytokine Interleukin-8 in Acute Pancreatitis

A. Jasińska, A. Mokrowiecka, E. Małecka-Panas, 2010, Pancreatology.

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS

W. Krajewska, J. Fichna, J. Timmermans, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression

J. Fichna, A. Mokrowiecka, D. Jacenik, 2021, Journal of inflammation research.

Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission

D. Saur, W. Krajewska, J. Timmermans, 2015, Journal of Molecular Medicine.

Transient Receptor Potential Vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?

W. Krajewska, A. Janecka, M. Storr, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Exploring the Relationship Between Self-Isolation and Distress Among People with Gastrointestinal Disorders During the COVID-19 Pandemic

A. Stengel, C. Bernstein, R. Gearry, 2021, Journal of Clinical Psychology in Medical Settings.

Colonic inflammation induces changes in glucose levels through modulation of incretin system

W. Krajewska, J. Fichna, A. Mokrowiecka, 2021, Pharmacological Reports.

New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration

R. Kordek, J. Fichna, A. Mokrowiecka, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases

W. Krajewska, R. Kordek, J. Fichna, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions

C. Bernstein, R. Gearry, I. Trindade, 2022, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Clinical utility of serological markers in inflammatory bowel disease.

A. Mokrowiecka, E. Małecka-Panas, P. Majak, 2009, Hepato-gastroenterology.

[Tumor necrosis factor alpha (TNF-alpha) and its receptors: sTNF-alphaRI i sTNF-alphaRII in chronic pancreatitis].

A. Mokrowiecka, E. Małecka-Panas, A. Gąsiorowska, 2005, Polskie Archiwum Medycyny Wewnetrznej.

The Involvement of the Endogenous Opioid System in the Gastrointestinal Aging in Mice and Humans

J. Fichna, A. Mokrowiecka, M. Talar, 2022, International journal of molecular sciences.

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study

P. Oprocha, A. Makriyannis, W. Krajewska, 2013, PloS one.

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

H. Bradshaw, W. Krajewska, R. Kordek, 2014, Journal of Crohn's & colitis.

Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors

W. Krajewska, R. Kordek, J. Fichna, 2017, Journal of Crohn's & colitis.

Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome

W. Krajewska, A. Mokrowiecka, E. Małecka-Panas, 2017, Molecular and Cellular Endocrinology.

Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort

A. Stengel, C. Bernstein, R. Gearry, 2021, Journal of Clinical Psychology in Medical Settings.

The position of a duodenal diverticulum in the area of the major duodenal papilla and its potential clinical implications.

M. Polguj, M. Podgórski, E. Jakubczyk, 2015, Folia morphologica.

Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system

W. Krajewska, R. Kordek, J. Fichna, 2019, Biochemical pharmacology.

p16 gene mutations in Barrett's esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence.

A. Mokrowiecka, E. Małecka-Panas, B. Smolarz, 2012, Advances in medical sciences.

Adiponectin and leptin receptors expression in Barrett's esophagus and normal squamous epithelium in relation to central obesity status.

J. Wieczfinska, D. Kacprzak, M. Sokolowska, 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Liver–Intestine-Cadherin Is a Sensitive Marker of Intestinal Differentiation During Barrett’s Carcinogenesis

M. Vieth, A. Hartmann, R. Kordek, 2012, Digestive Diseases and Sciences.

Orally administered novel cyclic pentapeptide P‐317 alleviates symptoms of diarrhoea‐predominant irritable bowel syndrome

W. Krajewska, J. Fichna, P. Wlaź, 2015, The Journal of pharmacy and pharmacology.

Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases

W. Krajewska, R. Kordek, J. Fichna, 2014, Pharmacological reports : PR.

Barrett's esophagus in 2016: From pathophysiology to treatment.

E. Savarino, A. Mokrowiecka, E. Małecka-Panas, 2016, World journal of gastrointestinal pharmacology and therapeutics.

The comparison of Health-Related Quality of Life (HRQL) in patients with GERD, peptic ulcer disease and ulcerative colitis.

A. Mokrowiecka, D. Pińkowski, E. Małecka-Panas, 2006, Advances in medical sciences.

The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study

A. Ford, A. Stengel, C. Bernstein, 2021, Journal of Psychosomatic Research.

Novel selective agonist of GPR18, PSB‐KK‐1415 exerts potent anti‐inflammatory and anti‐nociceptive activities in animal models of intestinal inflammation and inflammatory pain

K. Kieć‐Kononowicz, R. Kordek, J. Fichna, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical assessment of inflammatory bowel disease activity: a critical overview

J. Fichna, A. Mokrowiecka, E. Małecka-Panas, 2016 .

G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn’s disease

W. Krajewska, R. Kordek, J. Fichna, 2019, Scientific Reports.

Exploring the Impact of Covid-19-Related Perceptions on Psychological Distress and Quality of Life in an International Gastrointestinal Cohort Over Time Guided by the Common Sense Model

A. Stengel, C. Bernstein, I. Trindade, 2023, Journal of Clinical Psychology in Medical Settings.

A. Stengel, C. Bernstein, R. Gearry, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Dissecting the genetic heterogeneity of gastric cancer

H. Grabsch, M. Kogevinas, A. Metspalu, 2023, EBioMedicine.

Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission

D. Saur, W. Krajewska, J. Timmermans, 2015, Journal of Molecular Medicine.

Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.

A. Jasińska, D. Orszulak-Michalak, A. Mokrowiecka, 2012, Hepato-gastroenterology.

Circulating Levels of Visfatin, Resistin and Pro-Inflammatory Cytokine Interleukin-8 in Acute Pancreatitis

A. Jasińska, A. Mokrowiecka, E. Małecka-Panas, 2010, Pancreatology.

Amplification of Her-2/neu oncogene in GERD - Barrett's metaplasia – dysplasia - adenocarcinoma sequence.

A. Mokrowiecka, E. Małecka-Panas, B. Smolarz, 2013, Hepato-gastroenterology.